Serum india, Company

New Delhi, Jan 25 Four days back Bangladesh received two million doses of vaccines from India as a gift. It is also sitting smug over a successful deal it signed with the Serum Institute of India (SII) late last year for a supply of 30 million coronavirus vaccines.Bangladesh is a shining example of how China lost out with an ally it had been courting in South Asia. Chinese vaccine firm Sinovac Biotec's arm twisting of Bangladesh fell flat after the government decided to cancel Sinovac's contract for conducting trials and providing vaccines.China had been interacting with Bangladesh regarding the pandemic when the Covid-19 crisis was at its peak with most nations confused and helpless but for imposing lockdowns. As far back as June 2020, China had sent medical teams to Dhaka to support the South Asian nation understand and tackle the pandemic. Beijing also assured Bangladesh of speedy delivery of vaccines.Separately, Bangladesh had an agreement with Sinovac under which it had to conduct mass trials of the Sinovac vaccine in return for free doses. However, the Bangladesh health ministry released information over developments in September and October 2020 that Sinovac asked it to co-fund the trials. Noticing a breach of contract, Bangladesh Health Minister Zahid Maleque cancelled Sinovac's contract and immediately reached out to India's SII for the vaccines.Bangladesh Prime Minister Sheikh Hasina also followed up on the vaccines. She raised the matter with Prime Minister Narendra Modi during their online summit in December and he promised to facilitate the delivery of the vaccines to Dhaka under the 'Neighbourhood First' policy.Now, numerous countries in different geographies have started to reject the Chinese vaccines for myriad reasons. The Hindustan Times reports that as China falls out of favour, India is receiving requests for vaccine supply. It reports: "Several countries that have been offered or purchased Chinese Covid-19 vaccines, including Brazil and Cambodia, have turned to India for supplies of the AstraZeneca vaccine amid questions about the efficacy of some of the Chinese jabs."In December last year, the Ministry of External Affairs had provided vaccination training to friendly countries. Though most were South Asian nations, the training was provided to countries as diverse as Mongolia, Oman, Morocco, Brazil and a handful of others. MEA Spokesperson Anurag Srivastava said: "There is interest in many countries in accessing vaccines from India which is the global hub for vaccine production."China has taken note of the developments. The Communist Party of China mouthpiece, Global Times has run a number of articles on India's coronavirus vaccines and their distribution. In a recent article, it quipped: "Choosing Nepal, Bangladesh, and Sri Lanka among the first batch of countries to receive Covid-19 vaccines shows India's mentality of competition with China. India believes that it has already won over the Maldives, but it still needs to win over Nepal." The newspaper is keeping a hawk's eye on all activity happening on the vaccine front in India and its neighbourhood.With India pushing both vaccines - the AstraZeneca vaccine Covishield by SII as well as the home-grown Covaxin by Bharat Biotech, its credibility as a drug-maker of repute grows by the day. What is also vindicated is it's humanitarian effort in the face of vaccine hypocrisy and a deathly pandemic that raced across the world from Wuhan, China.(This content is being carried under an arrangement with indianarrative.com)( With inputs from IANS )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Serum IndiaFOLLOW

Serum india, Latest News

Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 ...

India's drug regulatory body has received requests from both Pune based Serum Institute of India and Hyderabad-based Bharat Biotech to make necessary changes in the vaccine fact sheet to allow people using blood thinners to get inoculated against Cov ...

As Bahrain on Thursday received a consignment of 10,800 'Made in India' coronavirus vaccines, External Affairs Minister S Jaishankar said that the delivery of the vaccines is a testimony of long-standing fraternal ties between the two countries. ...

After providing coronavirus vaccines to several countries including Bangladesh, Nepal and Maldives, India on Thursday established its position as a reliable partner in COVID-19 assistance by dispatching Covishield vaccines to Bahrain and Sri Lanka. ...

Nepal on Wednesday began its nationwide inoculation drive after receiving one million Covishield vaccines, manufactured by the Serum Institute of India (SII), from the Indian government last week. ...

Lauding the country's scientists for their success in manufacturing vaccines against coronavirus in record time, President Ram Nath Kovind on Monday urged citizens to "utilise the lifeline" and get vaccinated against COVID-19 according to laid down g ...

India's gift of 1.5 million doses of Covid-19 vaccines to neighbouring Myanmar as part of its "Vaccine Maitri" drive will strengthen bilateral ties between the two neighbours, said Indian ambassador to Myanmar, Saurabh Kumar. ...

New Delhi, Jan 25 Four days back Bangladesh received two million doses of vaccines from India as a ... ...